Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor update to the study details page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision stamp updated from v3.6.4 to v3.6.5 on the page, signaling a minor backend/template update. No study content or user-facing data are altered by this change.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3; this reflects a minor update to the page's revision metadata.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.0. This is a platform/software update and does not modify the study data or how the page presents trial information.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded recruitment status note 'No longer looking for participants' and new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header formatting was updated, and the revision tag was updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.4%

- Check98 days agoChange DetectedRevision: v3.5.5 was applied to the page, signaling a minor maintenance update. This change does not modify any study details, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.